Intended Use:

AESKULISA® SpA detect is a solid phase enzyme immunoassay with recombinant human CD74 for the semi-quantitative determination of IgA antibodies against human CD74 in the serum. The test is used for diagnosing SpA (spondyloarthritis) and accordingly for clarifying the origin of inflammatory or chronic back pain. It is not a screening assay and is not used for the differential diagnosis of rheumatoid arthritis and systemic lupus erythematosus (SLE).

Recombinant Antigens:

Recombinant human CD74

Native Antigens:

n.a.